CIK: 0002010850
Total reported value
$661.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGON | Cg Oncology INC | Stock-Other | 35.59% | +29.62% | — | |
| 2 | NUVB | Nuvation Bio INC | Stock-Other | 31.28% | -14.44% | — | |
| 3 | UPB | Upstream Bio INC | Stock-Other | 11.48% | -7.77% | -4.33% | |
| 4 | AARD | Aardvark Therapeutics INC | Stock-Other | 6.92% | -4.69% | — | |
| 5 | LYEL | Lyell Immunopharma, Inc. | Stock-Other | 2.87% | -0.77% | +16.22% | |
| 6 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 2.79% | -1.22% | -9.89% | |
| 7 | RVMD | Revolution Medicines INC | Stock-Healthcare | 2.14% | -0.76% | -4.76% | |
| 8 | RCUS | Arcus Biosciences INC | Stock-Other | 1.74% | -0.18% | -1.10% | |
| 9 | ACRS | Aclaris Therapeutics INC | Stock-Other | 1.64% | +0.65% | — | |
| 10 | EQ | Equillium INC | Stock-Other | 0.93% | +0.41% | — | |
| 11 | ✓ | Beyondspring INC Shs | Stock-Other | 0.83% | +0.11% | -11.32% | |
| 12 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 0.58% | -0.58% | EXIT | |
| 13 | KRYS | Krystal Biotech INC | Stock-Healthcare | 0.57% | -0.28% | -46.44% | |
| 14 | AURA | Aura Biosciences INC | Stock-Other | 0.26% | -0.26% | EXIT | |
| 15 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 0.24% | +0.23% | — | |
| 16 | PYXS | Pyxis Oncology INC | Stock-Other | 0.05% | +0.02% | — | |
| 17 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.04% | -0.04% | EXIT | |
| 18 | NUVB-WS | Nuvation Bio INC -cw27 | Stock-Other | 0.03% | -0.03% | EXIT | |
| 19 | RZLT | Rezolute INC | Stock-Other | 0.02% | -0.02% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NUVB | Nuvation Bio INC | +14.5% | — | Unchanged |
| 2 | LYEL | Lyell Immunopharma, Inc. | +1.2% | +16.22% | Add |
| 3 | UPB | Upstream Bio INC | +0.7% | -4.33% | Trim |
| 4 | RCUS | Arcus Biosciences INC | +0.4% | -1.10% | Trim |
| 5 | RVMD | Revolution Medicines INC | +0.4% | -4.76% | Trim |
| 6 | ACRS | Aclaris Therapeutics INC | +0.3% | — | Unchanged |
| 7 | NUVB-WS | Nuvation Bio INC -cw27 | 0% | — | Unchanged |
| 8 | RZLT | Rezolute INC | -0.1% | — | Unchanged |
| 9 | PYXS | Pyxis Oncology INC | -0.1% | — | Unchanged |
| 10 | FDMT | 4d Molecular Therapeutics In | -0.1% | -52.22% | Trim |
| 11 | ZNTL | Zentalis Pharmaceuticals INC | -0.1% | — | Unchanged |
| 12 | EQ | Equillium INC | -0.2% | — | Unchanged |
| 13 | AURA | Aura Biosciences INC | -0.3% | -30.08% | Trim |
| 14 | KRYS | Krystal Biotech INC | -0.4% | -46.44% | Trim |
| 15 | CRNX | Crinetics Pharmaceuticals In | -0.5% | -35.17% | Trim |
| 16 | NAMS | NewAmsterdam Pharma Company N.V. | -0.5% | -9.89% | Trim |
| 17 | ✓ | Beyondspring INC Shs | -0.5% | -11.32% | Trim |
| 18 | AARD | Aardvark Therapeutics INC | -2.2% | — | Unchanged |
| 19 | CGON | Cg Oncology INC | -9.2% | — | Unchanged |
| 20 | ✓ | Merus N V | — | EXIT | Sold out |
| 21 | ✓ | Moonlake Immunotherapeutics | — | EXIT | Sold out |
| 22 | ILMN | Illumina INC | — | EXIT | Sold out |
| 23 | GRAL | Grail INC | — | EXIT | Sold out |